Zytiga, also known by its generic name abiraterone, is a drug that is used to treat men with advanced prostate cancer which has become resistant to hormone therapy.
It is a relatively new drug and only recently was approved by the FDA for use in a certain subset of men with prostate cancer.
Zytiga represents an important step forward as it has a unique mechanism of action and is one of only a handful of drugs that has been approved for men with advanced prostate cancer.
You can read much more about Zytiga.
Comments
No comments yet. Leave a Comment
